On day 5, unhappy with the way I covered regulation of monopolist earlier, went over it again. To put some flesh on the bone, I asked at conclusion of the analysis if they would favor regulating the price of drug on which the seller had a patent? Some discomfort with the idea. A number suggested the need to provide incentives to invest in R&D. In response I asked why not compensate them for their R&D? Ask for the R&D costs and pay them that plus something extra if we want to cover opportunity cost. Some discussion of how one would monitor and verify these costs. At which point someone piped in that if R&D costs were difficult to monitor, why not have the Government just do the R&D? Now we really are on the road to socialized medicine. Some appeals to the efficiency of competitive markets which I put on hold with the promise that we would return to this issue later on in the semester.
Thus far class had been limited to a uniform price monopolist. Pivoted to discussing a multi-product monopolist by way of a small example of a durables good monopolist selling over two periods. Had the class act out out the role of buyers and me the seller cutting price over time. It provided an opportunity to discuss the role of commitment and tie it back to the ultimatum game played Day 1. On day 6 will revisit this with a discussion of JC Penny, which will allow one to get to next item on the agenda: price discrimination.